2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
1872
Neoplasms
1257
Colorectal Neoplasms
1059
Carcinoma, Non-Small-Cell Lung
1012
Stomach Neoplasms
803
Carcinoma, Hepatocellular
785
Lung Neoplasms
769
Prostatic Neoplasms
697
Pancreatic Neoplasms
577
Rectal Neoplasms
450
Ovarian Neoplasms
406
Neoplasm Metastasis
405
Colonic Neoplasms
405
Uterine Cervical Neoplasms
400
Recurrence
383
Leukemia, Myeloid, Acute
372
Esophageal Neoplasms
363
Multiple Myeloma
340
Lymphoma
335
Head and Neck Neoplasms
330
Melanoma
312
Precursor Cell Lymphoblastic Leukemia-Lymphoma
292
Brain Neoplasms
264
Urinary Bladder Neoplasms
256
Liver Neoplasms
225
Nasopharyngeal Carcinoma
223
Leukemia
218
Lymphoma, Large B-Cell, Diffuse
216
Polycystic Ovary Syndrome
210
Squamous Cell Carcinoma of Head and Neck
205
Interventions
Valsartan
1
Hydroxychloroquine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Glomerulonephritis
×
Clear all
NCT02765594
2017-09-20
HCQIgAN
Peking Union Medical College Hospital
Phase 4
Unknown
98 enrolled